These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19301646)

  • 1. In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi).
    Xiang S; Keates AC; Fruehauf J; Yang Y; Guo H; Nguyen T; Li CJ
    Methods Mol Biol; 2009; 487():147-60. PubMed ID: 19301646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencing.
    Nguyen TA; Fruehauf JH
    Methods Mol Biol; 2009; 514():27-34. PubMed ID: 19048211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
    Keates AC; Fruehauf J; Xiang S; Li CJ
    Biotechnol Genet Eng Rev; 2008; 25():113-27. PubMed ID: 21412352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals.
    Xiang S; Fruehauf J; Li CJ
    Nat Biotechnol; 2006 Jun; 24(6):697-702. PubMed ID: 16699500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi.
    Guo H; Zhang J; Inal C; Nguyen T; Fruehauf JH; Keates AC; Li CJ
    Gene Ther; 2011 Jan; 18(1):95-105. PubMed ID: 20811467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.
    Aigner A
    Expert Opin Biol Ther; 2009 Dec; 9(12):1533-42. PubMed ID: 19769540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
    Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
    J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
    Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial delivery of siRNAs: a new approach to solid tumor therapy.
    Xu DQ; Zhang L; Kopecko DJ; Gao L; Shao Y; Guo B; Zhao L
    Methods Mol Biol; 2009; 487():161-87. PubMed ID: 19301647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic delivery of siRNAs for oligonucleotide therapy.
    Takeshita F; Hokaiwado N; Honma K; Banas A; Ochiya T
    Methods Mol Biol; 2009; 487():83-92. PubMed ID: 19301643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
    Höbel S; Aigner A
    Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
    Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
    Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput selection of effective RNAi probes for gene silencing.
    Kumar R; Conklin DS; Mittal V
    Genome Res; 2003 Oct; 13(10):2333-40. PubMed ID: 14525931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.